|
Monos, Dimitri S; Pappas, John; Magira, Eleni E et al. (2005) Identification of HLA-DQalpha and -DRbeta residues associated with susceptibility and protection to epithelial ovarian cancer. Hum Immunol 66:554-62
|
|
Pappas, John; Jung, Weon-Ju; Barda, Angeliki K et al. (2005) Substantial proportions of identical beta-chain T-cell receptor transcripts are present in epithelial ovarian carcinoma tumors. Cell Immunol 234:81-101
|
|
Platsoucas, Chris D; Fincke, John E; Pappas, John et al. (2003) Immune responses to human tumors: development of tumor vaccines. Anticancer Res 23:1969-96
|
|
Kooi, S; Zhang, H Z; Patenia, R et al. (1996) HLA class I expression on human ovarian carcinoma cells correlates with T-cell infiltration in vivo and T-cell expansion in vitro in low concentrations of recombinant interleukin-2. Cell Immunol 174:116-28
|
|
Freedman, R S; Platsoucas, C D (1996) Immunotherapy for peritoneal ovarian carcinoma metastasis using ex vivo expanded tumor infiltrating lymphocytes. Cancer Treat Res 82:115-46
|
|
Nash, M A; Platsoucas, C D; Wong, B Y et al. (1995) Transduction of rIL-2 expanded CD4+ and CD8+ ovarian TIL-derived T cell lines with the G1Na (neor) replication-deficient retroviral vector. Hum Gene Ther 6:1379-89
|
|
Freedman, R S; Tomasovic, B; Templin, S et al. (1994) Large-scale expansion in interleukin-2 of tumor-infiltrating lymphocytes from patients with ovarian carcinoma for adoptive immunotherapy. J Immunol Methods 167:145-60
|
|
Lee, J E; Reveille, J D; Ross, M I et al. (1994) HLA-DQB1*0301 association with increased cutaneous melanoma risk. Int J Cancer 59:510-3
|
|
Chen, P F; Freedman, R S; Chernajovsky, Y et al. (1994) Amplification of immunoglobulin transcripts by the non-palindromic adaptor polymerase chain reaction (NPA-PCR). Nucleotide sequence analysis of two human monoclonal antibodies recognizing two cell surface antigens expressed in ovarian, cervix, breast, col Hum Antibodies Hybridomas 5:131-42
|
|
Freedman, R S; Edwards, C L; Kavanagh, J J et al. (1994) Intraperitoneal adoptive immunotherapy of ovarian carcinoma with tumor-infiltrating lymphocytes and low-dose recombinant interleukin-2: a pilot trial. J Immunother Emphasis Tumor Immunol 16:198-210
|
Showing the most recent 10 out of 13 publications
